College of Public Health, Medical and Veterinary Science, James Cook University, 1/14-88 McGregor Road, Smithfield, QLD, 4878, Australia.
Centre for Tropical Bioinformatics and Molecular Biology, James Cook University, 1 James Cook Dr, Douglas, QLD, 4811, Australia.
Eur J Pediatr. 2022 Sep;181(9):3389-3400. doi: 10.1007/s00431-022-04548-y. Epub 2022 Jul 7.
Preterm infants suffer from a higher incidence of acute diseases such as necrotising enterocolitis and sepsis. This risk can be mitigated through probiotic prophylaxis during admission. This reduction in risk is likely the result of acute modulation of the gut microbiome induced by probiotic species, which has been observed to occur up until discharge. We aimed to determine if this modulation, and the associated probiotic species, persisted beyond discharge. We conducted both a cross-sectional analysis (n = 18), at ~ 18 months of age, and a longitudinal analysis (n = 6), from admission to 18 months of the gut microbiome of preterm infants using both shotgun metagenomics and 16S rRNA profiling respectively. The 16S amplicon sequencing revealed that the microbial composition of the probiotic-supplemented infants changed dramatically over time, stabilising at discharge. However, species from the probiotic Infloran, as well as positive modulatory effects previously associated with supplementation, do not appear to persist beyond discharge and once prophylaxis has stopped. Conclusions: Although differences exist between supplemented and non-supplemented groups, the implications of these differences remain unclear. Additionally, despite a lack of long-term colonisation, the presence of probiotics during early neonatal life may still have modulatory effects on the microbiome assembly and immune system training. What is Known: • Evidence suggests modulation of the microbiome occurs during probiotic prophylaxis, which may support key taxa that exert positive immunological benefits. • Some evidence suggests that this modulation can persist post-prophylaxis. What is New: • We present support for long-term modulation in association with probiotic prophylaxis in a cohort of infants from North Queensland Australia. • We also observed limited persistence of the probiotic species post-discharge.
早产儿易患坏死性小肠结肠炎和败血症等急性疾病。通过住院期间的益生菌预防,可以降低这种风险。这种风险的降低可能是由于益生菌物种诱导的肠道微生物组的急性调节所致,这种调节一直持续到出院。我们旨在确定这种调节以及相关的益生菌物种是否在出院后仍然存在。我们分别使用 shotgun 宏基因组学和 16S rRNA 分析,对接受益生菌预防的早产儿的肠道微生物组进行了横断面分析(n=18),在~18 个月龄时进行,以及纵向分析(n=6),从入院到 18 个月龄。16S 扩增子测序结果表明,补充益生菌的婴儿的微生物组成随时间发生了巨大变化,在出院时稳定下来。然而,来自益生菌Infloran 的物种以及以前与补充相关的正向调节作用似乎并没有在出院后和预防停止后持续存在。结论:尽管补充组和非补充组之间存在差异,但这些差异的影响仍不清楚。此外,尽管缺乏长期定植,但在新生儿早期存在益生菌可能仍然对微生物组组装和免疫系统训练具有调节作用。已知的:•证据表明,益生菌预防过程中微生物组发生调节,这可能支持发挥积极免疫益处的关键分类群。•有证据表明,这种调节可以在预防后持续存在。新的:•我们为澳大利亚北昆士兰州婴儿队列中与益生菌预防相关的长期调节提供了支持。•我们还观察到出院后益生菌物种的持续存在有限。